Celadon Pharmaceuticals Advances Despite Funding Delays

Celadon Pharmaceuticals PLC (GB:CEL) has released an update.

Celadon Pharmaceuticals PLC, a UK-based company specializing in cannabis-based medicines, recently fulfilled its initial UK orders and is actively managing its financial position, despite delays in funding. The company is making operational progress, such as supplying cannabis Active Pharmaceutical Ingredients to UK private clinics, and is in talks with potential lenders for substantial new debt facilities. Celadon’s financial stability over the next year hinges on the anticipated receipt of equity fundraising and committed credit facility funds.

For further insights into GB:CEL stock, check out TipRanks’ Stock Analysis page.